Logista launches flu campaign: Logista stock sits 1.91 percent below its yearly high

Published on 10/19/2026 at 10:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Logista forecasts 6 million doses at 3,200 points on October 6, 2026. Logista stock costs EUR 37.04 on October 19, 2026, 1.91 percent below its high.

Pharma logistics and valuation

Logista forecast 6 million influenza doses across 3,200 supply points on October 6, 2026.
JB Capital Markets lifted its target from EUR 33.70 to EUR 35.50 on October 13, 2026.
Logista stock traded at EUR 37.04 at 10:02 a.m. CEST at Lang & Schwarz on October 19, 2026, 1.91 percent below its 52-week high.
Logista reported EUR 281.0 million in net profit for fiscal year 2025.

Logista, ES0105027009, Illustration mit AI erstellt.

Logista launched a pharmaceutical logistics campaign forecast to move 6 million influenza vaccine doses through more than 3,200 supply points, while Logista stock sat 1.91 percent below its 52-week high at EUR 37.04 on October 19, 2026. The company announced the campaign on October 6, 2026, in a release from Logista.

Pharma adds a measurable growth lever

The campaign gives Logista a concrete operating workload during the autumn vaccination period. The company said its main laboratory partner expected to distribute more than 4.6 million vaccines in 2026, while the Madrid service involved 840,320 doses and 206,720 vials across about 900 delivery points.

Logista also said transport capacity rises from 16 vehicles to more than 40 at peak demand, an increase of more than 150 percent. That operating intensity makes pharmaceutical logistics a useful counterweight to the tobacco distribution business, where volume trends have been less supportive.

What does the target reset mean?

JB Capital Markets raised its Logista target from EUR 33.70 to EUR 35.50 on October 13, 2026, and retained a neutral recommendation, according to XTB. The revised target was already below the October 19 Lang & Schwarz quote, so the change improved the valuation reference without creating a fresh upside case at that price.

Three dated valuation signals

In April 2026, JB Capital Markets had raised its target from EUR 33.60 to EUR 33.70. In July 2026, its target remained EUR 33.70. On October 13, 2026, the target rose to EUR 35.50, according to XTB.

Results date comes next

Logista's next reported results are scheduled for November 6, 2026, according to Simply Wall St. The date will give investors a fresh test of the pharmaceutical contribution and the broader distribution margin.

Fiscal year 2025 sets the earnings base

For fiscal year 2025, Logista reported economic sales of EUR 1.809 billion, adjusted EBIT of EUR 378.0 million and net profit of EUR 281.0 million on its company website. Net profit was down 8.8 percent from EUR 308.0 million in fiscal year 2024, according to Simply Wall St.

Stock remains near its yearly high

Logista stock was trading at EUR 37.04 at Lang & Schwarz on October 19, 2026 at 10:02 a.m. CEST, 1.91 percent below its 52-week high of EUR 37.76. The quote places the stock near the upper end of its EUR 28.16 to EUR 37.76 52-week range as of October 19, 2026. The further course of trading is shown by the continuously updated real-time quote of Logista stock.